NASDAQ:BBH VanEck Biotech ETF (BBH) Price, Holdings, & News → The Single Biggest Breakthrough of the Decade (From Porter & Company) (Ad) Free BBH Stock Alerts $167.46 -0.72 (-0.43%) (As of 06/13/2024 ET) Add Compare Share Share Today's Range$167.01▼$167.8050-Day Range$151.99▼$169.8152-Week Range$142.51▼$171.04Volume7,138 shsAverage Volume4,686 shsMarket Capitalization$435.41 millionAssets Under Management$432.33 millionDividend Yield0.42%Net Expense Ratio0.35% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Get VanEck Biotech ETF alerts: Email Address About VanEck Biotech ETF (NASDAQ:BBH)The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.Read More BBH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BBH ETF News HeadlinesMarch 29, 2024 | benzinga.comFuture-Proof Your Portfolio: Learn From ETF Expert Jan Van Eck In NYCMarch 22, 2024 | seekingalpha.comGNOM: Genomics Still Waiting For Its 'ChatGPT' MomentJanuary 30, 2024 | msn.comVanEck CEO Says Cryptos Deserve A Place In Everyone's PortfolioDecember 19, 2023 | msn.comVanEck Vectors Biotech ETF declares annual distribution of $0.7127December 9, 2023 | seekingalpha.comBBH: A Solid Way To Play A Comeback In BiotechOctober 24, 2023 | investing.comBBH ETF Stock Price HistorySeptember 13, 2023 | msn.comBBH: Our Favorite Biotech ETF Can Keep OutperformingAugust 7, 2023 | morningstar.comVanEck ETFsSee More Headlines Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVan Eck Fund NameVanEck Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$432.33 million Average Daily Volume$5,513.80 Discount/Premium0.06% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest1,900 shs Miscellaneous Outstanding Shares2,650,000Beta0.85 Creation Unit50,000 Creation Fee$500.00 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Ad The Freeport SocietyThe last Republican president?History shows Donald Trump is poised to go down as the last Republican President for a generation or more. How is this possible, with Biden so unpopular, and Trump running at least neck-in-neck with him in polls?This presentation explains exactly why. VanEck Biotech ETF ExpensesTypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.35%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.54%-0.22%-0.56%Net Expense0.35%0.60%0.60%0.54%0.58% VanEck Biotech ETF (BBH) Holdings & ExposureTop 10 BBH HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 15.74%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 10.68%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 7.95%Moderna(NASDAQ:MRNA)Holding Weight: 7.66%Gilead Sciences(NASDAQ:GILD)Holding Weight: 6.91%Biogen(NASDAQ:BIIB)Holding Weight: 4.75%ICON Public(NASDAQ:ICLR)Holding Weight: 4.29%argenx(NASDAQ:ARGX)Holding Weight: 4.25%IQVIA(NYSE:IQV)Holding Weight: 4.20%Illumina(NASDAQ:ILMN)Holding Weight: 3.41%BBH Sector ExposureBBH Industry ExposureFull Holdings Details Similar ETFsVanEck Pharmaceutical ETFNASDAQ:PPHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQInstitutional OwnershipWilliams Jones Wealth Management LLC.Sold 210 shares on 5/8/2024Ownership: 0.083%Valley Wealth Managers Inc.Bought 2,146 shares on 5/4/2024Ownership: 0.729%Conservest Capital Advisors Inc.Sold 670 shares on 5/2/2024Ownership: 0.715%Janney Montgomery Scott LLCSold 150 shares on 5/1/2024Ownership: 0.161%Commonwealth Equity Services LLCBought 340 shares on 4/29/2024Ownership: 1.127%View All Institutional Transactions BBH ETF - Frequently Asked Questions How have BBH shares performed in 2024? VanEck Biotech ETF's stock was trading at $165.31 at the beginning of 2024. Since then, BBH shares have increased by 1.3% and is now trading at $167.4650. View the best growth stocks for 2024 here. Are investors shorting VanEck Biotech ETF? VanEck Biotech ETF saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 1,900 shares, a drop of 34.5% from the May 15th total of 2,900 shares. Based on an average daily trading volume, of 7,000 shares, the short-interest ratio is currently 0.3 days. View VanEck Biotech ETF's Short Interest. How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF? VanEck Biotech ETF declared an annual dividend on Friday, December 15th. Stockholders of record on Tuesday, December 19th will be given a dividend of $0.7127 per share on Friday, December 22nd. The ex-dividend date of this dividend is Monday, December 18th. Read our dividend analysis for BBH. What does BBH invest in? VanEck Biotech ETF is a equity fund issued by Van Eck. BBH focuses on health care investments and follows the Market Vectors US Listed Biotech 25 Index. The fund's investments total to approximately $432.33 million assets under management. What stocks does VanEck Biotech ETF hold? BBH invests in 26 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Moderna (MRNA), Gilead Sciences (GILD), Biogen (BIIB), ICON Public (ICLR), argenx (ARGX), IQVIA (IQV) and Illumina (ILMN). What is the management fee for VanEck Biotech ETF? VanEck Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for BBH is 0.35%. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Novavax (NVAX). Who are VanEck Biotech ETF's major shareholders? VanEck Biotech ETF's stock is owned by many different institutional and retail investors. Top institutional shareholders include Commonwealth Equity Services LLC (1.13%), Valley Wealth Managers Inc. (0.73%), Conservest Capital Advisors Inc. (0.72%), Altfest L J & Co. Inc. (0.29%), Aspiriant LLC (0.16%) and Janney Montgomery Scott LLC (0.16%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BBH) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.